Piper Sandler Downgrades Tourmaline Bio (TRML) to Neutral
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Price: $47.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi downgraded Tourmaline Bio (NASDAQ: TRML) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Tourmaline Bio click here. For more ratings news on Tourmaline Bio click here.
Shares of Tourmaline Bio closed at $47.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 22nd Century Group files prospectus for warrant share resale
- Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
- MicroVision applies to transfer listing to NASDAQ capital market
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
